Renalytix Plc

Research Renalytix Plc (RENX.L) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 3.00M-USD 20.40M-USD 17.90M40.0%-0.07USD 3.60MUSD 8.30M-USD 7.00M
FY2024USD 2.30M-USD 45.50M-USD 29.80M8.7%-0.31USD 4.70MUSD 8.50M-USD 9.00M
FY2023USD 3.40M-USD 45.61M-USD 34.09M21.2%-0.56USD 24.68MUSD 12.12MUSD 6.97M
FY2022USD 2.97M-USD 45.28M-USD 46.59M29.4%-0.82USD 41.33MUSD 12.34MUSD 30.61M

About Renalytix Plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.

Related stock research

United Kingdom stocks United Kingdom Healthcare stocks A-Z stock index

Other Healthcare stocks

Cambridge Cognition Holdings Plc (COG) Craneware Plc (CRW) Diaceutics PLC (DXRX) Feedback PLC (FDBK) Kooth plc (KOO) MedPal AI PLC (MPAL.L) Optima Health plc (OPT) Physitrack PLC (PTRK) 4BASEBIO UK SOCIETAS (4BB) Abingdon Health Plc (ABDX) Allergy Therapeutics (AGY) Advanced Medical Solutions Group plc (AMS.L)

Frequently asked questions

What does Renalytix Plc do?

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.